Vibativ

Active Ingredient(s): Telavancin
FDA Approved: * September 11, 2009
Pharm Company: * THERAVANCE INC
Category: Antibiotics

Telavancin (trade name Vibativ) is a bactericidal lipoglycopeptide for use in MRSA or other Gram-positive infections. Telavancin is a semi-synthetic derivative of vancomycin.[1][2] The FDA approved the drug in September 2009 for complicated skin and skin structure infections (cSSSI),[3] and in June 2013 for hospital-acquired and ventilator-associated bacterial pneumonia caused by Staphylococcus aureus.[4] Contents 1 History 2 M... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Vibativ 250 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 0469-3525

Labeler:

Astellas Pharma Us Inc.

Vibativ 750 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 0469-3575

Labeler:

Astellas Pharma Us Inc.

Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 52118-001

Labeler:

Theravance, Inc.

Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 52118-002

Labeler:

Theravance, Inc.

Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 62847-001

Labeler:

Theravance Biopharma Antibiotics, Inc.

Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 62847-002

Labeler:

Theravance Biopharma Antibiotics, Inc.

Vibativ 15 mg/mg Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 66220-315

Labeler:

Cumberland Pharmaceuticals Inc.